S&P 5007,623.68▼0.5% Nasdaq25,955.34▼0.2% Dow52,215.16▼1.2% Russell 2K2,775.90▼0.3% 10-Yr4.99%+4bp VIX19.45+0.42 WTI$103.44▲4.0% Gold$4,010.00▼1.2% EUR/USD1.120▼0.3% BTC$80,550▼0.9% Nikkei62,908▼2.6%
At close · Sat, Oct 24, 2026
Daily Market Updates.

US Markets

Home›US Markets›Equities›Moderna’s cancer vaccine hits its targets, but a data…

Moderna’s cancer vaccine hits its targets, but a data leak rattled investors and the stock tumbled

Reported · Written up by our desk · Equities

A ‘sell-the-news reaction’? The experimental treatment helped prevent the return of cancer or death in melanoma patients by 42% after two years.

← Newer storyTreasury blueprints carve-outs from ROAD’s Wall Street BTR ban

More like this

US MarketsFrance’s Avoids a Debt Downgrade From Moody’s, but Is Given a Warning
US MarketsMoody's holds steady on France's credit rating as country grapples with turmoil and higher yields
US MarketsStocks, Pulled in Two Directions, Fall to End Volatile Week
US MarketsWhite House says the US is lifting tariffs on some Canadian goods
US MarketsStock Selloff Continues as Oil Surges

Sources

MarketWatchModerna’s cancer vaccine hits its targets, but a data leak rattled investors and the stock tumbled
MarketWatchModerna’s cancer vaccine hits its targets, but a data leak rattled investors and the stock tumbled

Get the close, explained.

One email every trading day: what moved, why it moved, and what's on deck tomorrow. Read in 3 minutes.

Free. Unsubscribe anytime.